If you can now change your body, do you still have to love it? And can wanting to lose weight coexist with body acceptance?
Hosted by journalist Rose Stokes, who brings 30 years of lived experience with weight and obesity, and Dr Giles Yeo, a University of Cambridge scientist who has spent three decades studying why people are small, medium or large in our food environment, this podcast brings together lived experience and science without pretending to have all the answers.
In this episode, Rose and Giles explore what happened to body positivity and where it leaves us in the age of GLP-1 weight-loss medication. In a deeply personal conversation, Rose reflects on what the movement meant to her, the disappearance of bigger bodies from fashion and media, and why choosing to lose weight doesn’t mean abandoning everything she believes about acceptance.
We cover:
• Whether BMI is scientifically meaningless, or simply too limited to tell the whole story
• The “SkinnyTok” claim that hunger is a good thing
• Why fatphobia affects people across the weight spectrum
• The retreat from plus-size representation in fashion and advertising
• Why body acceptance and looking after your health don’t have to be at odds
• How celebrity culture and shifting beauty standards influence what we consider an “acceptable” body
• The difficulty of discussing extreme thinness without scrutinising someone else’s health
• Why blaming GLP-1 medication for the return of thinness culture misses the bigger picture
• Plus, Rose revisits her Herbalife experience, involving meal-replacement shakes, French food and an awkward encounter at customs
This episode contains a paid partnership with Wild Nutrition. Visit https://www.wildnutrition.com/amatteroffat to learn more about the offer mentioned in the show.
Transparency:
Professor Giles Yeo consults and speaks for Novo Nordisk, Eli Lilly and Amgen, and has received research grant funding from Novo Nordisk and Amgen. He is joining Amgen’s cardiometabolic scientific advisory board and also consults for Voy. Industry funds most obesity research, and these relationships are typical for senior researchers in the field.
Rose Stokes has taken GLP-1 medication and writes about weight and the pharmaceutical industry as a freelance journalist.
FOLLOW to stay up to date with A Matter of Fat.
FIND US
Instagram: https://www.instagram.com/amatteroffatpod/
Rose Stokes: https://www.instagram.com/rosestokes/
Giles Yeo: https://www.instagram.com/gilesyeo/
Questions, thoughts, constructive criticism or a story you want to share? Email us at amatteroffatpod@gmail.com
","author_name":"Rose Stokes & Professor Giles Yeo"}